Broadfin Healthcare Master Fund Ltd's Net Worth
$82 Million
Who is Broadfin Healthcare Master Fund Ltd?
Broadfin Healthcare Master Fund Ltd has an estimated net worth of $82 Million. This is based on reported shares across multiple companies, which include BIODELIVERY SCIENCES INTERNATIONAL INC, Retrophin, Inc., Mirati Therapeutics, Inc., AVADEL PHARMACEUTICALS PLC, Recro Pharma, Inc., ARATANA THERAPEUTICS, INC., STRATA Skin Sciences, Inc., QLT INC/BC, Corium International, Inc., PROGENICS PHARMACEUTICALS INC, Aegerion Pharmaceuticals, Inc., and CARDICA INC.
SEC CIK
Broadfin Healthcare Master Fund Ltd's CIK is 0001511900
Past Insider Trading and Trends
2014 was Broadfin Healthcare Master Fund Ltd's most active year for acquiring shares with 5 total transactions. Broadfin Healthcare Master Fund Ltd's most active month to acquire stocks was the month of June. 2017 was Broadfin Healthcare Master Fund Ltd's most active year for disposing of shares, totalling 78 transactions. Broadfin Healthcare Master Fund Ltd's most active month to dispose stocks was the month of October. 2015 saw Broadfin Healthcare Master Fund Ltd paying a total of $7,500,014.80 for 646,553 shares, this is the most they've acquired in one year. In 2017 Broadfin Healthcare Master Fund Ltd cashed out on 9,099,336 shares for a total of $43,093,835.18, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BIODELIVERY SCIENCES INTERNATIONAL INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -7.59M |
—
|
—
|
0
|
Mar 22
| |||
Form 4
| +46.89% | 2.42M |
$1.80 | $4,359,999.60 | 7.59M |
Feb 11
| |||
Form 4
| +0.15% | 7.68K |
—
|
—
| 5.17M |
Jan 27
| |||
Form 4
| +1.98% | 100K |
$3.06 | $306,000.00 | 5.16M |
Nov 19
| |||
Form 4
| +2.02% | 100K |
$3.20 | $320,000.00 | 5.06M |
Nov 12
| |||
Form 4
| +5.48% | 257.8K |
$3.47 | $894,566.00 | 4.96M |
Nov 5
| |||
Form 4
| +0.97% | 45K |
$2.93 | $43,950.00 | 4.7M |
Aug 6 - Aug 10
| |||
Form 4
| +6.89% | 300K |
$3.20 | $960,500.00 | 4.66M |
May 11 - May 13
| |||
Form 4
| +1.04% | 45K |
$2.93 | $43,950.00 | 4.36M |
Aug 7
| |||
Form 4
| -0.25% | -10.62K |
$2.93 | -$31,125.39 | 4.31M |
Mar 17
| |||
Form 4
|
—
|
0
|
$4.10 | -$9,205,000.00 | 4.3M |
Dec 18 - Dec 20
| |||
Form 4
|
—
|
0
|
$3.89 | -$16,703,254.06 | 4.3M |
Nov 15 - Nov 18
| |||
Form 4
| +0.42% | 18.12K |
—
|
—
| 4.3M |
Aug 13
| |||
Form 4
| -29.60% | -1.80M |
$5.00 | -$9,000,000.00 | 4.28M |
May 10
| |||
Form 4
| -31.84% | -2.00M |
$5.00 | -$10,000,000.00 | 4.28M |
Apr 11
| |||
Form 4
|
∞
| 3.12K |
—
|
—
| 3.12K |
Aug 14
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Retrophin, Inc. (TVTX) Snapshot price: $10.98
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Mirati Therapeutics, Inc. (MRTX) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -2.15% | -60.00K |
$18.05 | -$1,083,000.00 | 2.73M |
Nov 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AVADEL PHARMACEUTICALS PLC (AVDL) Snapshot price: $14.5
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 7
| |||
Form 4
| +0.90% | 27.9K |
—
|
—
| 3.13M |
Jan 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| -5.94% | -261.00K |
$10.68 | -$2,786,600.00 | 4.13M |
Jun 22 - Jun 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| -100.00% | -4.39M |
—
|
—
|
0
|
Jan 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Recro Pharma, Inc. (SCTL) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -8.41% | -188.00K |
$5.81 | -$1,093,182.00 | 2.05M |
May 24
| |||
Form 4
| -8.21% | -200.00K |
$10.07 | -$2,014,000.00 | 2.24M |
Mar 13
| |||
Form 4
| -3.03% | -76.00K |
$9.87 | -$750,240.00 | 2.44M |
Dec 20 - Dec 21
| |||
Form 4
| -3.58% | -93.24K |
$9.86 | -$919,127.60 | 2.51M |
Dec 12 - Dec 13
| |||
Form 4
| -3.70% | -100.00K |
$10.00 | -$1,000,000.00 | 2.61M |
Dec 5
| |||
Form 4
| -7.60% | -222.62K |
$9.58 | -$2,133,062.55 | 2.71M |
Nov 28 - Nov 30
| |||
Form 4
| -5.55% | -172.21K |
$9.45 | -$1,626,564.87 | 2.93M |
Nov 21 - Nov 24
| |||
Form 4
| +26.53% | 650K |
$6.00 | $3,900,000.00 | 3.1M |
Dec 13
| |||
Form 4
| +18.93% | 390K |
$7.50 | $2,925,000.00 | 2.45M |
Aug 16
| |||
Form 4
| +45.74% | 646.55K |
$11.60 | $7,500,014.80 | 2.06M |
Jul 7
| |||
Form 4
| +20.59% | 241.34K |
$2.50 | $603,345.00 | 1.41M |
Dec 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||